Triumph Over Denial: Securing Lifesaving Treatment for a Brave Cancer Patient
Our 74-year-old client is bravely battling anaplastic thyroid cancer, one of the most aggressive and lethal forms of the disease. Her survival depends on a cutting-edge combination of targeted chemotherapy drugs, Braftovi and Mektovi. Despite confirmation from her expert physicians…
